Works matching IS 13520504 AND DT 2014 AND VI 21 AND IP 5


Results: 9
    1
    2
    3
    4
    5

    Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin.

    Published in:
    Journal of Viral Hepatitis, 2014, v. 21, n. 5, p. 357, doi. 10.1111/jvh.12151
    By:
    • Harada, N.;
    • Hiramatsu, N.;
    • Oze, T.;
    • Morishita, N.;
    • Yamada, R.;
    • Hikita, H.;
    • Miyazaki, M.;
    • Yakushijin, T.;
    • Miyagi, T.;
    • Yoshida, Y.;
    • Tatsumi, T.;
    • Kanto, T.;
    • Kasahara, A.;
    • Oshita, M.;
    • Mita, E.;
    • Hagiwara, H.;
    • Inui, Y.;
    • Katayama, K.;
    • Tamura, S.;
    • Yoshihara, H.
    Publication type:
    Article
    6
    7
    8
    9

    Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan.

    Published in:
    Journal of Viral Hepatitis, 2014, v. 21, n. 5, p. 366, doi. 10.1111/jvh.12153
    By:
    • McDonald, S. A.;
    • Hutchinson, S. J.;
    • Innes, H. A.;
    • Allen, S.;
    • Bramley, P.;
    • Bhattacharyya, D.;
    • Carman, W.;
    • Dillon, J. F.;
    • Fox, R.;
    • Fraser, A.;
    • Goldberg, D. J.;
    • Kennedy, N.;
    • Mills, P. R.;
    • Morris, J.;
    • Stanley, A. J.;
    • Wilks, D.;
    • Hayes, P. C.
    Publication type:
    Article